Company: MLTX
Filing Date: 2025-02-26
Form Type: 10-K
Source: 0001821586-25-000006
Chunk: 160

Company: MoonLake Immunotherapeutics
Filing Date: 2025-02-26
Form: 10-K
Item: Item 7
Chunk 160
---
 $150.8 million in proceeds received from maturities of short-term marketable debt securities with original maturities longer than three months.

Cash Flows from Financing Activities

During the year ended December 31, 2024, net cash provided by financing activities was $51.3 million consisting primarily of $52.5 million in net proceeds from the shares sold under the August 2023 Sales Agreement. During the year ended December 31, 2023, net cash provided by financing activities was $479.7 million consisting primarily of $482.5 million in the net proceeds from the shares sold under the Sales Agreements and the Offering.  

86

MOONLAKE IMMUNOTHERAPEUTICSFORM 10-K FOR THE YEAR ENDED DECEMBER 31, 2024PART II

Contractual Obligations and Commitments

The following summarizes our significant contractual obligations and other obligations as of December 31, 2024, which we generally expect to satisfy with cash on hand and the maturity of short-term marketable debt securities:

TotalLess than 1 year1 to 5 YearsPurchase obligations(1)$220,873,390 $150,955,740 $69,917,650 Lease commitments(2)2,978,4291,468,3131,510,116Total contractual obligations$223,851,819 $152,424,053 $71,427,766 

____________

(1)   Purchase obligations refer to an agreement to purchase goods or services that is enforceable and legally binding on the Company that specifies all significant terms. The figures presented primarily relate to contractual commitments towards contract manufacturing and contract research organizations.

(2)    We have committed ourselves to five leases, with terms that commenced on November 1, 2021, October 9, 2023, October 13, 2023, January 15, 2024, and September 8, 2024. These future lease commitments relate to the office leases for our headquarters in Zug, Switzerland, Cambridge, United Kingdom, and Porto, Portugal, and reflect minimum payments due.

Critical Accounting Policies and Estimates

The preparation of the consolidated financial statements in accordance with U.S. GAAP requires us to make judgments, estimates and assumptions that affect the reported amounts of assets, liabilities, expenses and related disclosures. We continually evaluate these judgments, estimates and assumptions based on the most recently available information, our own historical experience and various other assumptions